November 2026 Clinical Policy Review
The following clinical policies have undergone review with some added criteria requirements that may impact the prior authorization process. Please see the revision log within each policy to review the changes:
Annual Review:
- CP.MP.54 Hospice Services
- CP.MP.249 Allogenic Hematopoietic Progenitor Cell Therapy
- CP.MP.108 Allogeneic Hematopoietic Cell Transplants for Sickle Cell Anemia and Beta-thalassemia
- CP.MP.185 Skin and Soft Tissue Substitutes
- CP.MP.132 Heart and Lung Transplant
Newly Created Policies:
- CP.MP.254 Gender Affirming Procedures for Adults
- CP.MP.255 Gender Affirming Care for Adolescents
These changes go into effect on December 15, 2026. Clinical policies are located on our Clinical & Payment Policies page.